This system efficiently inhibited the glioma cell proliferation, successfully induced the protumor TAM2 towards antitumor TAM1 and triggered macrophage-directed anti-glioma immunotherapy via TAM, regulatory T cells, CD8+ T cells and cytokines 72. Here, CD8A is linked to glioma.